21 Evaluation of the singleplex SureScreen SARS-CoV-2 Antigen Rapid Test Cassette in community testing sites from February 2021 to April 2021 showed a sensitivity of 72.5% (95% CI 67.1% to 77.4%) for ...

“An improved vaccine would ideally generate a resident memory population in the nasal mucosa or at the site of entry itself ... intranasal vaccination induced better cross-protection against different ...

Asian businesswoman uses a rapid self-test of antigens. An Asian businesswoman uses a rapid self-test of antigens using a cotton swab to prick her nose to detect the coronavirus, COVID-19. rapid ...

Disinfecting surfaces is crucial in keeping bacteria and viruses at bay, but the cleaning solutions could be ineffective if ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...